Immunoglobulin G antibody response to the Sputnik V vaccine: previous SARS-CoV-2 seropositive individuals may need just one vaccine dose
Open Access
- 1 October 2021
- journal article
- research article
- Published by Elsevier in International Journal of Infectious Diseases
- Vol. 111, 261-266
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Antibody Responses after a Single Dose of SARS-CoV-2 mRNA VaccineNew England Journal of Medicine, 2021
- Binding and Neutralization Antibody Titers After a Single Vaccine Dose in Health Care Workers Previously Infected With SARS-CoV-2JAMA, 2021
- Antibody Responses in Seropositive Persons after a Single Dose of SARS-CoV-2 mRNA VaccineNew England Journal of Medicine, 2021
- Antibody Response to the BNT162b2 mRNA COVID-19 Vaccine in Subjects with Prior SARS-CoV-2 InfectionViruses, 2021
- Antibody response to first BNT162b2 dose in previously SARS-CoV-2-infected individualsThe Lancet, 2021
- Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in RussiaThe Lancet, 2021
- Sputnik V COVID-19 vaccine candidate appears safe and effectiveThe Lancet, 2021
- Recent Smell Loss Is the Best Predictor of COVID-19 Among Individuals With Recent Respiratory SymptomsChemical Senses, 2020
- Prevalence of SARS-CoV-2 in Spain (ENE-COVID): a nationwide, population-based seroepidemiological studyThe Lancet, 2020
- Predictive Value of Sudden Olfactory Loss in the Diagnosis of COVID-19ORL, 2020